Akebia Therapeutics (NASDAQ:AKBA) Downgraded by StockNews.com to Sell
Akebia Therapeutics (NASDAQ:AKBA – Get Free Report) was downgraded by research analysts at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Monday. Separately, HC Wainwright reissued a “buy” rating and issued a $7.50 target price on shares of Akebia Therapeutics in a research report on Wednesday, October […]
More Stories
Barclays PLC Buys 19,290 Shares of General Mills, Inc. (NYSE:GIS)
Barclays PLC grew its position in General Mills, Inc. (NYSE:GIS – Free Report) by 1.2% during the 3rd quarter, according...
Brophy Wealth Management LLC Purchases Shares of 2,121 Capital One Financial Co. (NYSE:COF)
Brophy Wealth Management LLC bought a new position in Capital One Financial Co. (NYSE:COF) during the 3rd quarter, Holdings Channel.com...
Dimensional Emerging Markets Core Equity 2 ETF (NYSEARCA:DFEM) Shares Purchased by Ballentine Capital Advisors Inc
Ballentine Capital Advisors Inc boosted its holdings in Dimensional Emerging Markets Core Equity 2 ETF (NYSEARCA:DFEM – Free Report) by...
Unigestion Holding SA Takes Position in American Express (NYSE:AXP)
Unigestion Holding SA acquired a new position in American Express (NYSE:AXP) in the 3rd quarter, according to the company in...
Discipline Wealth Solutions LLC Takes $654,000 Position in SPDR Gold Shares (NYSEARCA:GLD)
Discipline Wealth Solutions LLC acquired a new stake in SPDR Gold Shares (NYSEARCA:GLD – Free Report) during the third quarter,...
Virtue Capital Management LLC Sells 238 Shares of Broadcom Inc. (NASDAQ:AVGO)
Virtue Capital Management LLC trimmed its position in shares of Broadcom Inc. (NASDAQ:AVGO – Free Report) by 4.4% during the...